KineMed Enters into Collaboration with Bristol-Myers Squibb

KineMed has announced a two-year collaboration with Bristol-Myers Squibb to focus on Alzheimer’s disease and other neurodegenerative diseases. KineMed was a winner of one of Prize4Life’s Thought Prizes in the ALS Biomarker Challenge. They subsequently received funding from the Michael J. Fox Foundation to apply their work to Parkinson’s disease.

Click here for more information

Share this: